BIT:1CVAC - Euronext Milan - NL0015436031 - Common Stock - Currency: EUR
BIT:1CVAC (6/13/2025, 7:00:00 PM)
4.798
+2.3 (+91.92%)
The current stock price of 1CVAC.MI is 4.798 EUR.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
1ABBV.MI | ABBVIE INC | 18.55 | 293.65B | ||
4AB.DE | ABBVIE INC | 18.06 | 285.45B | ||
AMG.DE | AMGEN INC | 13.93 | 135.53B | ||
GIS.DE | GILEAD SCIENCES INC | 14.08 | 118.02B | ||
VX1.DE | VERTEX PHARMACEUTICALS INC | N/A | 99.95B | ||
1REGN.MI | REGENERON PHARMACEUTICALS | 11.89 | 49.56B | ||
ARGX.BR | ARGENX SE | 100.69 | 28.65B | ||
22UA.DE | BIONTECH SE-ADR | N/A | 22.10B | ||
IDP.DE | BIOGEN INC | 8.05 | 16.25B | ||
1EXEL.MI | EXELIXIS INC | 18.73 | 9.81B | ||
0QF.DE | MODERNA INC | N/A | 8.67B | ||
1MRNA.MI | MODERNA INC | N/A | 8.44B |
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Tuebingen, Baden-Wuerttemberg and currently employs 999 full-time employees. The company went IPO on 2020-08-14. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
CUREVAC NV
Friedrich-Miescher-Str. 15
Tuebingen BADEN-WUERTTEMBERG DE
Employees: 1086
Phone: 49707198830
The current stock price of 1CVAC.MI is 4.798 EUR. The price increased by 91.92% in the last trading session.
The exchange symbol of CUREVAC NV is 1CVAC and it is listed on the Euronext Milan exchange.
1CVAC.MI stock is listed on the Euronext Milan exchange.
15 analysts have analysed 1CVAC.MI and the average price target is 7.53 EUR. This implies a price increase of 56.88% is expected in the next year compared to the current price of 4.798. Check the CUREVAC NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CUREVAC NV (1CVAC.MI) has a market capitalization of 1.08B EUR. This makes 1CVAC.MI a Small Cap stock.
CUREVAC NV (1CVAC.MI) currently has 1086 employees.
The Revenue of CUREVAC NV (1CVAC.MI) is expected to grow by 112.91% in the next year. Check the estimates tab for more information on the 1CVAC.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
1CVAC.MI does not pay a dividend.
The PE ratio for CUREVAC NV (1CVAC.MI) is 9.05. This is based on the reported non-GAAP earnings per share of 0.53 and the current share price of 4.798 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1CVAC.MI.
ChartMill assigns a technical rating of 2 / 10 to 1CVAC.MI.
ChartMill assigns a fundamental rating of 4 / 10 to 1CVAC.MI. The financial health of 1CVAC.MI is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months 1CVAC.MI reported a non-GAAP Earnings per Share(EPS) of 0.53. The EPS increased by 138.45% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -50% | ||
ROE | -73.95% | ||
Debt/Equity | 0.09 |
ChartMill assigns a Buy % Consensus number of 77% to 1CVAC.MI. The Buy consensus is the average rating of analysts ratings from 15 analysts.
For the next year, analysts expect an EPS growth of 76.81% and a revenue growth 112.91% for 1CVAC.MI